The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Stage 2 of the EHR Incentive Program

Stage 2 of the EHR Incentive Program

October 7, 2011 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Meaningful Use encourages rheumatologists to align EHR use with patient career

Although reporting for Stage 1 of the Centers for Medicare and Medicaid Services (CMS) Electronic Health Record (EHR) Incentive Program began just this year, the rules, objectives, and measures for Stage 2 are already being established. Last June, the Office of the National Coordinator (ONC) for Health Information Technology (IT) presented CMS with its recommendations for Stage 2 of the CMS EHR Incentive Program which builds on the Stage 1 objectives supporting EHR utilization for data capture and sharing.

You Might Also Like
  • Deadline Approaches to Participate in Medicare EHR Incentive Program, aka Meaningful Use
  • What Does Stage 2 Meaningful Use Mean for Your Rheumatology Practice?
  • PQRS Reporting Critical for Rheumatologists to Avoid Penalty, Earn Incentive Payment
Explore This Issue
October 2011
Also By This Author
  • The American Board of Bada Bing

The CMS EHR Incentive Program offers incentive payments of up to $44,000 for eligible providers, including rheumatologists who successfully demonstrate meaningful use of their EHR system, meeting the program’s measure thresholds for established objectives. Under the provisions of the Health Information Technology for Economic and Clinical Health Act (HITECH), CMS estimates that between $14.1 and $27.5 billion in funding will be distributed through the EHR Meaningful Use incentive program.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

This incentive program is meant to not only lend support for the acquisition of EHR systems, but also to ensure that systems purchased are capable of meeting the minimum requirements for secondary utilization and exchange of health information. As the name implies, the incentive program focuses on how EHR systems are used in practice, rather than simply providing incentives for their purchase. The requirements for the program are meant to encourage providers to use the system as more than simply an electronic medical chart; by letting go of “paper thinking,” providers can begin to realize the potential for an electronically supported practice transformation leading to greater efficiency, improved quality, and effectively coordinated care.

As with Stage 1 objectives, the Stage 2 program should not be viewed as a list of unique items and thresholds to meet, but as building blocks to further drive advanced utilization of the EHR system for disease management, clinical decision support, medication management, support for patients’ access to their health information, quality measurement and research, and bidirectional communication of health data (see Figure 1).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

click for large version
Figure 1: What does meaningful EHR use look like in practice? It’s more than just a list of objectives and measures

Potential Stage 2 Objectives and Measures

Many of the proposed objectives and measures for Stage 2 of the CMS EHR Incentive Program have been carried over from Stage 1 of the program, with some adjustments to the measurement thresholds and with the designation of “core” or required objective applied to those that were “menu” or optional in Stage 1 (see Table 1). For most, this will mean that your practice will simply need to evaluate practice workflows to ensure that the entire practice team has an understanding of who is responsible for the clinical and administrative actions and that these actions are being done in a way that is consistent with measurement in the EHR system.

Pages: 1 2 3 | Single Page

Filed Under: Electronic Health Records, From the College, Information Technology, Technology Tagged With: CMS, electronic health record, Healthcare, information technology, Meaningful use, Medicare, Practice Management, TechnologyIssue: October 2011

You Might Also Like:
  • Deadline Approaches to Participate in Medicare EHR Incentive Program, aka Meaningful Use
  • What Does Stage 2 Meaningful Use Mean for Your Rheumatology Practice?
  • PQRS Reporting Critical for Rheumatologists to Avoid Penalty, Earn Incentive Payment
  • Meaningful Use Road Map: Steps to Get Started

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)